Your browser doesn't support javascript.
loading
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities.
Lu, Dan; Lu, Tong; Stroh, Mark; Graham, Richard A; Agarwal, Priya; Musib, Luna; Li, Chi-Chung; Lum, Bert L; Joshi, Amita.
Afiliação
  • Lu D; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Lu T; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Stroh M; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Graham RA; Department of Clinical Pharmacology, Theravance Biopharma U.S., Inc., South San Francisco, CA, USA.
  • Agarwal P; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Musib L; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Li CC; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
  • Lum BL; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA. blum@gene.com.
  • Joshi A; Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA.
Cancer Chemother Pharmacol ; 77(3): 459-76, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26811176

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article